Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Leask

Showing results (31-40 of 221) with videos related to

Pageof 23
Sort By:
Journal of Cell Communication and Signaling|April 18, 2016
CCN6: a modulator of breast cancer progressionAndrew Leask
Journal of Cell Communication and Signaling|January 8, 2013
CCN6: a novel method of aTAKing cancerAndrew Leask
Journal of Cell Communication and Signaling|February 22, 2012
Egr-ly awaiting a "personalized medicine" approach to treat sclerodermaAndrew Leask
Advances in Wound Care|February 15, 2014
Integrin <i>β</i>1: A Mechanosignaling Sensor Essential for Connective Tissue Deposition by FibroblastsAndrew Leask
Seminars in Immunopathology|July 5, 2015
Matrix remodeling in systemic sclerosisAndrew Leask
Journal of Cell Communication and Signaling|July 24, 2008
The Starbuck stops here: it's a Smad worldAndrew Leask
The Keio Journal of Medicine|July 13, 2004
Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosisAndrew Leask
Journal of Cell Communication and Signaling|October 17, 2009
A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cellsAndrew Leask
Journal of Cell Communication and Signaling|September 4, 2008
CCN2 YAPs at cancerAndrew Leask
Journal of Cell Communication and Signaling|April 13, 2011
CCN1: a novel target for pancreatic cancerAndrew Leask
Pageof 23

Showing results (31-40 of 221) with videos related to

Sort By:
Pageof 23
Journal of Cell Communication and Signaling|April 18, 2016
CCN6: a modulator of breast cancer progressionAndrew Leask
Journal of Cell Communication and Signaling|January 8, 2013
CCN6: a novel method of aTAKing cancerAndrew Leask
Journal of Cell Communication and Signaling|February 22, 2012
Egr-ly awaiting a "personalized medicine" approach to treat sclerodermaAndrew Leask
Advances in Wound Care|February 15, 2014
Integrin <i>β</i>1: A Mechanosignaling Sensor Essential for Connective Tissue Deposition by FibroblastsAndrew Leask
Seminars in Immunopathology|July 5, 2015
Matrix remodeling in systemic sclerosisAndrew Leask
Journal of Cell Communication and Signaling|July 24, 2008
The Starbuck stops here: it's a Smad worldAndrew Leask
The Keio Journal of Medicine|July 13, 2004
Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosisAndrew Leask
Journal of Cell Communication and Signaling|October 17, 2009
A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cellsAndrew Leask
Journal of Cell Communication and Signaling|September 4, 2008
CCN2 YAPs at cancerAndrew Leask
Journal of Cell Communication and Signaling|April 13, 2011
CCN1: a novel target for pancreatic cancerAndrew Leask
Pageof 23